Precision for Medicine Expands Internationally with New Office in Singapore

Precision for Medicine, a pioneering force in biomarker-based clinical research and development, has unveiled an important new office in Singapore. This move deepens the organization's footprint across the Asia-Pacific (APAC) region, marking a significant step in their ambition to enhance client support and expedite growth in highly strategic markets.

Jing Ping Yeo, Vice President of Clinical Operations at Precision, emphasized the importance of this expansion. He stated, "The new Singapore hub represents a vital enhancement of our operational capacity and local expertise throughout the APAC region. By entering critical markets like Singapore, we reassure our clients of our capability in managing clinical trials effectively and ensure they experience quicker site activation, leading to the successful delivery of complex biomarker-driven clinical programs for patients globally."

The establishment of an office in Singapore not only signifies growth but positions Precision strategically, thanks to Singapore's advantageous location and advanced infrastructure. From this hub, Precision aims to reach neighboring markets like Mainland China, Hong Kong, India, South Korea, Taiwan, and Australia. With over 500 dedicated employees stationed regionally, Precision shows its commitment to overcoming the challenges presented by drug development and commercialization in these diverse markets.

For global partners, Precision’s expansion reinforces its position as a cohesive Contract Research Organization (CRO), streamlining the process by acting as a single partner instead of a multitude of intermediaries. This unified approach results in clear accountability while enhancing the quality and consistency of clinical trial delivery. Regional clients will also benefit from the company’s ability to efficiently bring innovative therapies into comprehensive global development pathways, significantly accelerating their progress in markets such as the U.S. and Europe.

The leadership team in the new office consists of highly esteemed industry experts. Dr. Yeo not only leads the clinical operations but also holds prestigious positions with the Drug Information Association (DIA) Singapore Advisory Committee and the Singapore Clinical Research Professionals Association (SCRP). His insights and leadership are set to be invaluable as Precision navigates the intricacies of the APAC market.

Senior Vice President of APAC, James Cheong, expressed optimism regarding the new branch, stating, "This Singapore office is a strategic cornerstone in our ongoing quest to provide unparalleled support to precision medicine development both globally and in this rapidly evolving APAC landscape. Our new hub is designed for seamless integration between our robust global operations and localized insights from our teams."

Moreover, Daisy DeWeese-Gatt, President of Clinical Solutions at Precision, further commented, "The opening of our new office is not just a milestone; it significantly fortifies our presence in the APAC region. By leveraging diverse data and patient populations across the area, we aim to expedite the development of new medicines, ensuring they are appropriately tailored and representative of the real-world variety faced by patients, particularly those in high-need demographics."

Founded in 2019, Precision for Medicine has redefined the blueprint for clinical research organizations. By focusing on the integration of biomarker technologies, it aids life science companies in delivering more effective patient treatments. This unique approach combines deep scientific knowledge with advanced data analytics and laboratory expertise, resulting in faster, more efficient clinical development and approval processes. Precision for Medicine operates globally, boasting an impressive workforce of over 3,700 professionals across more than 50 locations worldwide, including North America, Europe, and now, a bolstered presence in the APAC region.

For media inquiries, please contact Brad Epstein at [email protected] for more information.